Moderna
MRNA
#290
Rank
โ‚น7.311 T
Marketcap
โ‚น18,071
Share price
-2.17%
Change (1 day)
742.62%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -โ‚น281.93 Billion

According to Moderna 's latest financial reports the company's current earnings are โ‚น2.21 Billion. In 2025 the company made an earning of -โ‚น255.59 Billion, an increase over its 2024 earnings that were of -โ‚น332.04 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น281.93 Billion10.31%
2025 -โ‚น255.59 Billion-23.03%
2024 -โ‚น332.04 Billion-8.22%
2023 -โ‚น361.79 Billion-140.65%
2022 โ‚น890.00 B-27.81%
2021 โ‚น1.232 T-1911.15%
2020 -โ‚น68.07 Billion44.7%
2019 -โ‚น47.04 Billion28.63%
2018 -โ‚น36.57 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
โ‚น1.734 T-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น1.171 T-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
โ‚น623.02 B-320.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-โ‚น4.4 Billion-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-โ‚น10.91 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-โ‚น3.88 Billion-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚น113.19 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-โ‚น14.78 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA